Acadia Pharmaceuticals Inc. (ACAD) vs iRhythm Technologies, Inc. (IRTC)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and iRhythm Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACAD vs IRTC

growth of $100 · dividends reinvested · last 10y
ACAD -17.3% (-1.9%/yr)IRTC +318.8% (+15.4%/yr)IRTC compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$83$419
ACAD IRTC

ACAD vs IRTC: by the numbers

  • •IRTC is the larger company ($3.53B vs $3.41B market cap).
  • •ACAD is profitable (33.42% net margin) while IRTC runs a net loss (-1.69%).
  • •IRTC grew revenue faster over the past five years (21.93% vs 19.70% CAGR).

Metrics side by side

Valuation

MetricACADIRTC
P/E ratio8.97N/A
Forward P/E32.31N/A
P/S ratio2.994.28
P/B ratio2.6118.98
EV / EBITDA31.48286.81
FCF yield5.12%1.10%

Profitability

MetricACADIRTC
Gross margin91.13%71.45%
Operating margin7.59%-1.17%
Net margin33.42%-1.69%
ROE29.12%-7.50%
ROIC6.25%-1.07%

Growth (annualized)

MetricACADIRTC
Revenue CAGR (5Y)19.70%21.93%
Total return CAGR (5Y)3.52%12.95%

Frequently asked

Which has grown faster, ACAD or IRTC?
Over the past five years, IRTC grew revenue faster — ACAD at a 19.70% CAGR versus IRTC at 21.93%.
Is ACAD or IRTC more profitable?
ACAD runs the higher net margin — ACAD at 33.42% versus IRTC at -1.69%.
How have ACAD and IRTC total returns compared?
Over the past 5 years, ACAD delivered 3.52% and IRTC delivered 12.95% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.